Journal article
Multicenter, Prospective, Controlled, Before-and-After, Quality Improvement Study (Stroke123) of Acute Stroke Care
DA Cadilhac, R Grimley, MF Kilkenny, NE Andrew, NA Lannin, K Hill, B Grabsch, CR Levi, AG Thrift, SG Faux, J Wakefield, G Cadigan, GA Donnan, S Middleton, CS Anderson
Stroke | LIPPINCOTT WILLIAMS & WILKINS | Published : 2019
Abstract
Background and Purpose-Hospital uptake of evidence-based stroke care is variable. We aimed to determine the impact of a multicomponent program involving financial incentives and quality improvement interventions, on stroke care processes. Methods-A prospective study of interventions to improve clinical care quality indicators at 19 hospitals in Queensland, Australia, during 2010 to 2015, compared with historical controls and 23 other Australian hospitals. After baseline routine audit and feedback (control phase, 30 months), interventions involving financial incentives (21 months) and then addition of externally facilitated quality improvement workshops with action plan development (9 months)..
View full abstractGrants
Awarded by Allergan
Funding Acknowledgements
The Stroke123 project was supported by the National Health and Medical Research Council (NHMRC) partnership grant 1034415, cofunded by Queensland Health, Monash University, and the Stroke Foundation of Australia. Financial incentives were funded by Queensland Health through their Quality Improvement Payment program. The following authors received research fellowship support from the NHMRC: Prof Cadilhac (1063761 cofunded Heart Foundation), Dr Andrew (1072053), Prof Anderson (1081356), Dr C. Levi (1043913), A/Prof Lannin (1112158), Prof Thrift (1042600), and Dr Kilkenny (1109426). The Australian Stroke Clinical Registry was supported by grants from the NHMRC (1034415), Monash University, Queensland Health, Victorian Department of Health and Human Services, Tasmanian government the Stroke Foundation, Allergan Australia, Ipsen, Boehringer Ingelheim, and consumer donations.